Preparation method of targeted liposome-encapsulated aqueous phase gold nanocomposite
A technology for targeting liposomes and gold nanoparticles, which can be used in liposome delivery, medical preparations with non-active ingredients, non-active ingredients of polymer compounds, etc., which can solve the problems of easy allergy, nephrotoxicity, short development time, etc. , to achieve the effect of simple process, satisfying production and application, and stable properties
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] 1. Preparation of targeted liposomes:
[0023] Dissolve sulfhydryl-modified polypeptide molecule SH-N1, 2.15mg in 1ml phosphate buffer solution (PBS, pH=7.0), maleimide-modified phospholipid molecule (DSPE-PEG-MAL) 8.9mg in 0.5ml N,N-Dimethylformamide (DMF). The DSPE-PEG-MAL solution was then added to the peptide solution. Bubbles were removed from the solution by sonication, followed by magnetic stirring for 1 hour.
[0024] Dilute the reaction solution to 5ml, put it into a dialysis bag for dialysis, and change the water every 1-2 hours to remove DMF, PBS, and unlinked polypeptide molecules. A phospholipid molecule (P-DSPE) linked to a polypeptide (P) is obtained. Freeze drying gave a solid product.
[0025] Mix 8 mg of hydrogenated soybean phospholipid (HSPC), 3.4 mg of cholesterol, and 1 mg of P-DSPE, add 2.5 ml of chloroform to dissolve in a round bottom flask, and then rotary evaporate at 41 ° C until a film is formed on the wall of the bottle. Place in a vac...
Embodiment 2
[0029] 1. Preparation of targeted liposomes
[0030] Dissolve 2.15 mg of sulfhydryl-modified peptide molecule SH-N2 targeting neuroflagellin in 1 ml of phosphate buffer solution (PBS, pH=7.0), maleimide-modified phospholipid molecule (DSPE- PEG-MAL) 8.9mg was dissolved in 0.5ml N,N-dimethylformamide (DMF). The DSPE-PEG-MAL solution was then added to the peptide solution. Bubbles were removed from the solution by sonication, followed by magnetic stirring for 1 hour.
[0031] Dilute the reaction solution to 5ml, put it into a dialysis bag for dialysis, and change the water every 1-2 hours to remove DMF, PBS, and unlinked polypeptide molecules. A phospholipid molecule (P-DSPE) linked to a polypeptide (P) is obtained. Freeze drying gave a solid product.
[0032] Mix 8 mg of hydrogenated soybean phospholipid (HSPC), 3.4 mg of cholesterol, and 1 mg of P-DSPE, add 2.5 ml of chloroform to dissolve in a round bottom flask, and then rotary evaporate at 41 ° C until a film is formed ...
Embodiment 3
[0036] 1. Preparation of targeted liposomes
[0037] Dissolve Toll-like receptor 4 antibody, 20ml (1mg / ml) in 1ml phosphate buffer solution (PBS, pH=7.0), 8.9mg of maleimide-modified phospholipid molecules (DSPE-PEG-MAL) in 0.5ml N,N-Dimethylformamide (DMF). The DSPE-PEG-MAL solution was then added to the peptide solution. Bubbles were removed from the solution by sonication, followed by magnetic stirring for 1 hour.
[0038] Dilute the reaction solution to 5ml, put it into a dialysis bag for dialysis, and change the water every 1-2 hours to remove DMF, PBS, and unlinked polypeptide molecules. A phospholipid molecule (P-DSPE) linked to a polypeptide (P) is obtained. Freeze drying gave a solid product.
[0039] Mix 8 mg of hydrogenated soybean phospholipid (HSPC), 3.4 mg of cholesterol, and 1 mg of P-DSPE, add 2.5 ml of chloroform to dissolve in a round bottom flask, and then rotary evaporate at 41 ° C until a film is formed on the wall of the bottle. Place in a vacuum ove...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

